ABT - Abbott Laboratories

NYSE - NYSE Delayed Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
43,653,000
43,653,000
43,075,000
34,608,000
31,904,000
Cost of Revenue
19,142,000
19,142,000
18,537,000
15,003,000
13,231,000
Gross Profit
24,511,000
24,511,000
24,538,000
19,605,000
18,673,000
Operating Expenses
Research Development
2,888,000
2,888,000
2,742,000
2,420,000
2,440,000
Selling General and Administrative
11,248,000
11,248,000
11,324,000
9,696,000
9,765,000
Total Operating Expenses
16,149,000
16,149,000
16,113,000
14,248,000
14,141,000
Operating Income or Loss
8,362,000
8,362,000
8,425,000
5,357,000
4,532,000
Interest Expense
558,000
375,000
490,000
500,000
576,000
Total Other Income/Expenses Net
319,000
319,000
276,000
111,000
121,000
Income Before Tax
8,306,000
8,306,000
8,211,000
4,968,000
4,077,000
Income Tax Expense
1,373,000
1,373,000
1,140,000
497,000
390,000
Income from Continuing Operations
6,933,000
6,933,000
7,071,000
4,471,000
3,687,000
Net Income
6,933,000
6,933,000
7,071,000
4,495,000
3,687,000
Net Income available to common shareholders
6,933,000
6,933,000
7,071,000
4,495,000
3,687,000
Basic EPS
-
-
4.01
2.54
2.09
Diluted EPS
-
-
3.94
2.50
2.06
Basic Average Shares
-
-
1,764,082
1,771,230
1,762,503
Diluted Average Shares
-
-
1,789,000
1,786,000
1,781,000
EBITDA
-
10,694,000
10,748,000
7,600,000
6,589,000